Selective serotonin reuptake inhibitors’ passage into human milk of lactating women

References

• Becker M, Weinberger T, Chandy A, et al. Depression during pregnancy and postpartum. Curr Psychiatry Rep. 2016;18(3):32.
   PubMed Web of Science ®Google Scholar
• Gelaye B, Rondon MB, Araya R, et al. Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries. Lancet Psychiatry. 2016;3(10):973–982.
   PubMed Web of Science ®Google Scholar
• Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol. 2015;30(1):4–20.
   PubMed Web of Science ®Google Scholar
• Gentile S. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf. 2007;30(2):107–121.
   PubMed Web of Science ®Google Scholar
• Jarde A, Morais M, Kingston D, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73(8):826–837.
   PubMed Web of Science ®Google Scholar
• Staneva A, Bogossian F, Pritchard M, et al. The effects of maternal depression, anxiety, and perceived stress during pregnancy on preterm birth: a systematic review. Women Birth. 2015;28(3):179–193.
   PubMed Web of Science ®Google Scholar
• Suri R, Lin AS, Cohen LS, et al. Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature. J Clin Psychiatry. 2014;75(10):e1142–e1152.
   PubMed Web of Science ®Google Scholar
• McDonagh MS, Matthews A, Phillipi C, et al. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis. Obstet Gynecol. 2014;124(3):526–534.
   PubMed Web of Science ®Google Scholar
• Szegda K, Markenson G, Bertone-Johnson ER, et al. Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med. 2014;27(9):960–967.
   PubMed Web of Science ®Google Scholar
• Altamura AC, De Gaspari IF, Rovera C, et al. Safety of SSRIs during pregnancy: a controlled study. Hum Psychopharmacol. 2013;28(1):25–28.
   PubMed Web of Science ®Google Scholar
• Alwan S, Friedman JM. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs. 2009;23(6):493–509.
   PubMed Web of Science ®Google Scholar
• Weisskopf E, Fischer CJ, Bickle Graz M, et al. Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence. Expert Opin Drug Saf. 2015;14(3):413–427.
   PubMed Web of Science ®Google Scholar
• Gentile S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf. 2005;28(2):137–152.
   PubMed Web of Science ®Google Scholar
• Gentile S, Rossi A, Bellantuono C. SSRIs during breastfeeding: spotlight on milk-to-plasma ratio. Arch Womens Ment Health. 2007;10(2):39–51.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Long-term effects of breastfeeding – a systematic review. Geneva: WHO. Retrieved from the WHO website; 2013. Available from: http://apps.who.int/iris/bitstream/10665/79198/1/9789241505307_eng.pdf?ua=1
   Google Scholar
• World Health Organization (WHO). Short-term effects of breastfeeding – a systematic review. Geneva: WHO. Retrieved from the WHO website; 2013. Available from: http://apps.who.int/iris/bitstream/10665/79198/1/9789241505307_eng.pdf?ua=1
   Google Scholar
• Islami F, Liu Y, Jemal A, et al. Breastfeeding and breast cancer risk by receptor status – a systematic review and meta-analysis. Ann Oncol. 2015;26(12):2398–2407.
   PubMed Web of Science ®Google Scholar
• Gentile S. Managing antidepressant treatment in pregnancy and puerperium. Careful with that axe, Eugene. Expert Opin Drug Saf. 2015;14(7):1011–1014.
   PubMed Web of Science ®Google Scholar
• Braun ML, Giugliani ER, Soares ME, et al. Evaluation of the impact of the baby-friendly hospital initiative on rates of breastfeeding. Am J Public Health. 2003;93(8):1277–1279.
   PubMed Web of Science ®Google Scholar
• Howe-Heyman A, Lutenbacher M. The baby-friendly hospital initiative as an intervention to improve breastfeeding rates: a review of the literature. J Midwif Womens Health. 2016;61(1):77–102.
   PubMed Web of Science ®Google Scholar
• Baldelli S, Fucile S, Cattaneo D, et al. Development of a LC-MS/MS method for therapeutic drug monitoring of antidepressants and antipsychotics in human plasma. Ther Drug Monit. 2011;33(3):528–529.
   Google Scholar
• Salazar FR, D’Avila FB, de Oliveira MH, et al. Development and validation of a bioanalytical method for five antidepressants in human milk by LC-MS. J Pharm Biomed Anal. 2016;129(5):502–508.
   PubMed Web of Science ®Google Scholar
• Weisskopf E, Panchaud A, Nguyen KA, et al. Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry. J Chromatogr B: Analyt Technol Biomed Life Sci. 2017;1057(1):101–109.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44(6):195–235.
   Web of Science ®Google Scholar
• Nice FJ, Luo AC. Medications and breast-feeding: current concepts. J Am Pharm Assoc. 2012;52(1):86–94.
   Google Scholar
• Tasnif Y, Morado J, Hebert MF. Pregnancy-related pharmacokinetic changes. Clin Pharmacol Ther. 2016;100(1):53–62.
   PubMed Web of Science ®Google Scholar
• Newport DJ, Ritchie JC, Knight BT, et al. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure. J Clin Psychiatry. 2009;70(9):1304–1310.
   PubMed Web of Science ®Google Scholar
• Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol. 2002;53(1):17–22.
   PubMed Web of Science ®Google Scholar